- QbD-based product development for Parenteral dosage form (Liquids, Lyophilized, Liposomal, Suspension, and Emulsion), Topical dosage form,Ophthalmic dosage form and Nasal dosage form.
- Designing drug products with 505 b(2) strategy within acceptable regulatory and proprietary limitations.
- Customizable services based on Client needs (Product development to Commercial supply)
- Dedicative project execution experts for each client to support product development
Nasal Solutions
- Solutions
Topicals Skincare
- Emulsion (O/W and W/O emulsion based)
- Ointment
orals-liquid
- Solutions
- Syrups
- Suspension
Formulations
- Depot Suspension Injections
- Nano-Emulsions
- Protein & Peptide injections
- Drug Device combinations
- NCE-1 and 505 (b) 2 strategies
